Analyses from the PCPT trial have shown that serum levels of IGF were not correlated with prostate cancer development; however, men who have high levels of IGF are more likely to be on anti-diabetic drugs such as metformin which have shown to have anti-cancer properties [38]. This evidence concerns the gene IGF1 and cancer.